Drug Shortage Report for ERTAPENEM FOR INJECTION

Last updated on 2022-09-21 History
Report ID 154473
Drug Identification Number 02496127
Brand name ERTAPENEM FOR INJECTION
Common or Proper name Ertapenem for Injection, 1g SD Vial 20mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) ERTAPENEM
Strength(s) 1G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR
Packaging size 20mL
ATC code J01DH
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-05-02
Estimated end date Unknown
Actual end date 2022-09-20
Shortage status Resolved
Updated date 2022-09-21
Company comments On 100% allocation.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2022-09-21 French Compare
v7 2022-09-21 English Compare
v6 2022-05-15 French Compare
v5 2022-05-15 English Compare
v4 2022-03-31 French Compare
v3 2022-03-31 English Compare
v2 2022-02-08 French Compare
v1 2022-02-08 English Compare

Showing 1 to 8 of 8